Is MIRA Pharmaceuticals, Stock a Good Investment?
MIRA Pharmaceuticals, Investment Advice | MIRA |
- Examine MIRA Pharmaceuticals,'s financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research MIRA Pharmaceuticals,'s leadership team and their track record. Good management can help MIRA Pharmaceuticals, navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Pharmaceuticals space and any emerging trends that could impact MIRA Pharmaceuticals,'s business and its evolving consumer preferences.
- Compare MIRA Pharmaceuticals,'s performance and market position to its competitors. Analyze how MIRA Pharmaceuticals, is positioned in terms of product offerings, innovation, and market share.
- Check if MIRA Pharmaceuticals, pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about MIRA Pharmaceuticals,'s stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in MIRA Pharmaceuticals, Common stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if MIRA Pharmaceuticals, Common is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine MIRA Pharmaceuticals, Stock
Researching MIRA Pharmaceuticals,'s stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 27.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.55. MIRA Pharmaceuticals, had not issued any dividends in recent years.
To determine if MIRA Pharmaceuticals, is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding MIRA Pharmaceuticals,'s research are outlined below:
| MIRA Pharmaceuticals, generated a negative expected return over the last 90 days | |
| MIRA Pharmaceuticals, has high historical volatility and very poor performance | |
| MIRA Pharmaceuticals, may become a speculative penny stock | |
| MIRA Pharmaceuticals, has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (11.98 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| MIRA Pharmaceuticals, generates negative cash flow from operations | |
| MIRA Pharmaceuticals, has a poor financial position based on the latest SEC disclosures | |
| About 27.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from finance.yahoo.com: MIRA Reveals Innovative Phase IIIa Protocol Design and Selection of Clinical Trial Site |
MIRA Pharmaceuticals, Quarterly Cash And Short Term Investments |
|
MIRA Pharmaceuticals, uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in MIRA Pharmaceuticals, Common. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to MIRA Pharmaceuticals,'s previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 29th of December 2023 Upcoming Quarterly Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View | |
| 30th of June 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact MIRA Pharmaceuticals,'s stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises MIRA Pharmaceuticals,'s investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-05-13 | 2024-03-31 | -0.1 | -0.12 | -0.02 | 20 | ||
2024-02-28 | 2023-12-31 | -0.23 | -0.3915 | -0.1615 | 70 | ||
2023-11-13 | 2023-09-30 | -0.08 | -0.26 | -0.18 | 225 |
MIRA Pharmaceuticals,'s market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 21.2 M.Market Cap |
|
MIRA Pharmaceuticals,'s profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (2.43) | (2.55) | |
| Return On Capital Employed | (1.95) | (1.85) | |
| Return On Assets | (2.43) | (2.55) | |
| Return On Equity | (2.74) | (2.60) |
Determining MIRA Pharmaceuticals,'s profitability involves analyzing its financial statements and using various financial metrics to determine if MIRA Pharmaceuticals, is a good buy. For example, gross profit margin measures MIRA Pharmaceuticals,'s profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of MIRA Pharmaceuticals,'s profitability and make more informed investment decisions.
Please note, the presentation of MIRA Pharmaceuticals,'s financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, MIRA Pharmaceuticals,'s management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of MIRA Pharmaceuticals,'s management manipulating its earnings.
Basic technical analysis of MIRA Stock
As of the 28th of November, MIRA Pharmaceuticals, secures the mean deviation of 5.08, and Risk Adjusted Performance of (0.04). In respect to fundamental indicators, the technical analysis model lets you check practical technical drivers of MIRA Pharmaceuticals,, as well as the relationship between them.MIRA Pharmaceuticals,'s insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific MIRA Pharmaceuticals, insiders, such as employees or executives, is commonly permitted as long as it does not rely on MIRA Pharmaceuticals,'s material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases MIRA Pharmaceuticals, insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Understand MIRA Pharmaceuticals,'s technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing MIRA Pharmaceuticals,'s various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (6.53) | |||
| Mean Deviation | 5.08 | |||
| Coefficient Of Variation | (1,454) | |||
| Standard Deviation | 7.31 | |||
| Variance | 53.48 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.52) | |||
| Total Risk Alpha | (1.66) | |||
| Treynor Ratio | (6.54) | |||
| Maximum Drawdown | 40.41 | |||
| Value At Risk | (10.69) | |||
| Potential Upside | 12.07 | |||
| Skewness | 1.29 | |||
| Kurtosis | 3.07 |
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (6.53) | |||
| Mean Deviation | 5.08 | |||
| Coefficient Of Variation | (1,454) | |||
| Standard Deviation | 7.31 | |||
| Variance | 53.48 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.52) | |||
| Total Risk Alpha | (1.66) | |||
| Treynor Ratio | (6.54) | |||
| Maximum Drawdown | 40.41 | |||
| Value At Risk | (10.69) | |||
| Potential Upside | 12.07 | |||
| Skewness | 1.29 | |||
| Kurtosis | 3.07 |
Consider MIRA Pharmaceuticals,'s intraday indicators
MIRA Pharmaceuticals, intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of MIRA Pharmaceuticals, stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 19064.23 | |||
| Daily Balance Of Power | (0.20) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 1.27 | |||
| Day Typical Price | 1.27 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.01) |
MIRA Stock media impact
Far too much social signal, news, headlines, and media speculation about MIRA Pharmaceuticals, that are available to investors today. That information is available publicly through MIRA media outlets and privately through word of mouth or via MIRA internal channels. However, regardless of the origin, that massive amount of MIRA data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of MIRA Pharmaceuticals, news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of MIRA Pharmaceuticals, relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to MIRA Pharmaceuticals,'s headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive MIRA Pharmaceuticals, alpha.
MIRA Pharmaceuticals, Corporate Executives
Elected by the shareholders, the MIRA Pharmaceuticals,'s board of directors comprises two types of representatives: MIRA Pharmaceuticals, inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MIRA. The board's role is to monitor MIRA Pharmaceuticals,'s management team and ensure that shareholders' interests are well served. MIRA Pharmaceuticals,'s inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MIRA Pharmaceuticals,'s outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michelle MBA | Secretary CFO | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MIRA Pharmaceuticals, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MIRA Pharmaceuticals,. If investors know MIRA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MIRA Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.55) | Return On Assets (1.78) | Return On Equity (7.49) |
The market value of MIRA Pharmaceuticals, is measured differently than its book value, which is the value of MIRA that is recorded on the company's balance sheet. Investors also form their own opinion of MIRA Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is MIRA Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MIRA Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect MIRA Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between MIRA Pharmaceuticals,'s value and its price, as these two are different measures arrived at by various means. Investors typically determine if MIRA Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MIRA Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.